DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
6.03
0.02 (0.33%)
At close: Aug 15, 2025, 3:59 PM
6.03
0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT
DiaMedica Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.11M | 2.59M | 3.02M | 4.13M | 14.07M | 2.1M | 4.54M | 2.23M | 5.84M | 2.15M | 4.73M | 2.77M | 3.06M | 3.03M | 4.71M | 16.22M | 2.23M | 3.33M |
Short-Term Investments | 25.93M | 33.73M | 41.12M | 46.06M | 39.99M | 44.42M | 48.35M | 44.23M | 34.53M | 26.51M | 28.77M | 33.31M | 35.38M | 38.02M | 40.41M | 31.88M | 19.07M | 20.07M |
Long-Term Investments | n/a | 1M | n/a | n/a | n/a | n/a | n/a | 9.75M | 20.3M | n/a | n/a | n/a | n/a | n/a | 40.41M | 31.88M | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 1.31M | 1.31M | 1.31M | 1.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40.41M | -31.88M | n/a | n/a |
Receivables | n/a | 253K | 236K | 290K | 391K | 399K | 369K | 310K | 188K | 57K | 82K | 75K | 88K | 168K | 130K | 104K | 16K | 337K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -188K | -57K | n/a | 9K | 108K | 103K | 113K | n/a | n/a | n/a |
Other Current Assets | 1.04M | 649K | 227K | n/a | 568K | 569K | n/a | n/a | 863K | n/a | n/a | 322K | 534K | 793K | n/a | n/a | n/a | n/a |
Total Current Assets | 31.08M | 37.42M | 44.61M | 50.77M | 55.01M | 47.48M | 53.67M | 47.89M | 41.23M | 29.67M | 33.84M | 36.49M | 39.17M | 42.11M | 45.44M | 48.54M | 21.63M | 24.2M |
Property-Plant & Equipment | 391K | 408K | 427K | 449K | 469K | 468K | 485K | 507K | 523K | 543K | 560K | 551K | 85K | 100K | 112K | 127K | 145K | 161K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 391K | 1.41M | 1.74M | 1.76M | 1.78M | 1.78M | 485K | 10.25M | 20.82M | 543K | 560K | 551K | 85K | 100K | 112K | 127K | 145K | 161K |
Total Assets | 31.47M | 38.83M | 46.34M | 52.52M | 56.79M | 49.26M | 54.16M | 58.14M | 62.05M | 30.22M | 34.4M | 37.04M | 39.26M | 42.21M | 45.55M | 48.66M | 21.77M | 24.36M |
Account Payables | 1.26M | 1.51M | 940K | 1.17M | 759K | 716K | 926K | 863K | 856K | 1.78M | 734K | 864K | 624K | 433K | 509K | 699K | 239K | 689K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23K | 7K | 7K |
Short-Term Debt | 108K | n/a | n/a | 102K | 100K | 86K | 83K | 80K | 79K | n/a | n/a | n/a | n/a | 34K | n/a | 64K | n/a | 69K |
Other Current Liabilities | 4.01M | 341K | 1.06M | 2.1M | 1.5M | 1.26M | 928K | 577K | 456K | 795K | 698K | 334K | 687K | 817K | 482K | 430K | 941K | 311K |
Total Current Liabilities | 4.12M | 4.67M | 5.39M | 4.3M | 3.09M | 2.62M | 2.79M | 2.17M | 1.95M | 2.81M | 2.17M | 1.54M | 1.54M | 1.43M | 1.52M | 1.62M | 1.44M | 1.18M |
Long-Term Debt | 184K | n/a | n/a | 263K | 288K | 294K | 317K | n/a | 361K | n/a | n/a | 420K | 7K | 9K | n/a | 4K | 16K | 33K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | -288K | -294K | -317K | n/a | -361K | n/a | n/a | -420K | -7K | -9K | n/a | -4K | -16K | -33K |
Total Long-Term Liabilities | 184K | 211K | 237K | 263K | 288K | 294K | 317K | 340K | 361K | 381K | 400K | 420K | 7K | 9K | 3K | 4K | 16K | 33K |
Total Liabilities | 4.3M | 4.88M | 5.63M | 4.56M | 3.38M | 2.91M | 3.1M | 2.51M | 2.31M | 3.19M | 2.57M | 1.96M | 1.54M | 1.44M | 1.53M | 1.63M | 1.46M | 1.21M |
Total Debt | 292K | 316K | 340K | 365K | 388K | 380K | 400K | 420K | 440K | 459K | 469K | 461K | 25K | 43K | 52K | 68K | 85K | 102K |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -155.41M | -147.71M | -140M | -132.1M | -125.83M | -120.71M | -115.56M | -110.4M | -105.93M | -101.45M | -96.18M | -92.43M | -89.37M | -86.01M | -82.5M | -79.25M | -75.81M | -72.53M |
Comprehensive Income | -14K | 5K | 23K | 81K | -51K | -39K | 6K | -127K | -63K | -29K | -74K | -162K | -167K | -107K | -51K | -5K | -3K | -4K |
Shareholders Equity | 27.17M | 33.95M | 40.72M | 47.96M | 53.41M | 46.35M | 51.06M | 55.63M | 59.74M | 27.02M | 31.83M | 35.08M | 37.72M | 40.77M | 44.02M | 47.04M | 20.32M | 23.14M |
Total Investments | n/a | 34.73M | 41.12M | 46.06M | 39.99M | 44.42M | 48.35M | 53.98M | 54.83M | 26.51M | 28.77M | 33.31M | 35.38M | 38.02M | 80.81M | 63.76M | 19.07M | 20.07M |